<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName nlm2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">9724649</article-id><article-id pub-id-type="doi">10.3389/fimmu.2022.1040233</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Crosstalk between cytotoxic CD8+ T cells and stressed cardiomyocytes triggers development of interstitial cardiac fibrosis in hypertensive mouse hearts</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Brassington</surname><given-names>Kurt</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn003" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1767974"/></contrib><contrib contrib-type="author"><name><surname>Kanellakis</surname><given-names>Peter</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn003" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Cao</surname><given-names>Anh</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Toh</surname><given-names>Ban-Hock</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Peter</surname><given-names>Karlheinz</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/465157"/></contrib><contrib contrib-type="author"><name><surname>Bobik</surname><given-names>Alex</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/654244"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kyaw</surname><given-names>Tin</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1960912"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Inflammation and Cardiovascular Disease Laboratory, Baker Heart and Diabetes Institute</institution>, <addr-line>Melbourne, VIC</addr-line>, <country>Australia</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Centre for Inflammatory Diseases, Department of Medicine, Monash Medical Centre</institution>, <addr-line>Clayton, VIC</addr-line>, <country>Australia</country>
</aff><aff id="aff3">
<sup>3</sup>
<institution>Baker Department of Cardiometabolic Health, University of Melbourne</institution>, <addr-line>Parkville, VIC</addr-line>, <country>Australia</country>
</aff><aff id="aff4">
<sup>4</sup>
<institution>Department of Immunology, Monash University</institution>, <addr-line>Melbourne, VIC</addr-line>, <country>Australia</country>
</aff><author-notes><fn fn-type="edited-by"><p>Edited by: Matthias Mack, University Medical Center Regensburg, Germany</p></fn><fn fn-type="edited-by"><p>Reviewed by: Barbara Mara Klinkhammer, University Hospital RWTH Aachen, Germany; Salvador Iborra, Universidad Complutense de Madrid, Spain</p></fn><corresp id="fn001">*Correspondence: Tin Kyaw, <email xlink:href="mailto:tin.kyaw@baker.edu.au">tin.kyaw@baker.edu.au</email>
</corresp><fn fn-type="equal" id="fn003"><p>&#x02020;These authors have contributed equally to this work</p></fn><fn fn-type="other" id="fn002"><p>This article was submitted to Inflammation, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>22</day><month>11</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>13</volume><elocation-id>1040233</elocation-id><history><date date-type="received"><day>09</day><month>9</month><year>2022</year></date><date date-type="accepted"><day>31</day><month>10</month><year>2022</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2022 Brassington, Kanellakis, Cao, Toh, Peter, Bobik and Kyaw</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Brassington, Kanellakis, Cao, Toh, Peter, Bobik and Kyaw</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract abstract-type="graphical"><title>Graphical Abstract</title><p>Cardiac fibrosis developed from fibrotic remodelling due to hypertension leads to heart failure. Immune cells are abundantly accumulated in fibrotic regions, but exact mechanisms how they contributed to cardiac fibrosis are not clear. Here we demonstrated that CD8 T cells are major contributor to cardiac fibrosis in hypertensive hearts. Stressed cardiomyocytes express STING-dependent RAE-1 that activates NKG2D + CD8 T cells to induce apoptosis of stressed cardiomyocytes. Preventing STING signalling in stressed cardiomyocytes attenuates cardiac fibrosis. Pharmacologically inhibiting cardiomyocayte-RAE-1 and CD8+ T cell-NKG2D axis may be a potential therapeutic strategy to prevent cardiac fibrosis in HFpEF patients.</p><p>
<graphic xlink:href="fimmu-13-1040233-graphical-abstract.jpg" position="float" id="f9"/>
</p></abstract><abstract><sec><title>Aims</title><p>Cardiac fibrosis is central to heart failure (HF), especially HF with preserved ejection fraction (HFpEF), often caused by hypertension. Despite fibrosis causing diastolic dysfunction and impaired electrical conduction, responsible for arrhythmia-induced sudden cardiac death, the mechanisms are poorly defined and effective therapies are lacking. Here we show that crosstalk between cardiac cytotoxic memory CD8+ T cells and overly stressed cardiomyocytes is essential for development of non-ischemic hypertensive cardiac fibrosis.</p></sec><sec><title>Methods and results</title><p>CD8 T cell depletion in hypertensive mice, strongly attenuated CF, reduced cardiac apoptosis and improved ventricular relaxation. Interaction between cytotoxic memory CD8+ T cells and overly stressed cardiomyocytes is highly dependent on the CD8+ T cells expressing the innate stress-sensing receptor NKG2D and stressed cardiomyocytes expressing the NKG2D activating ligand RAE-1. The interaction between NKG2D and RAE-1 results in CD8+ T cell activation, release of perforin, cardiomyocyte apoptosis, increased numbers of TGF-&#x003b2;1 expressing macrophages and fibrosis. Deleting NKG2D or perforin from CD8+ T cells greatly attenuates these effects. Activation of the cytoplasmic DNA-STING-TBK1-IRF3 signaling pathway in overly stressed cardiomyocytes is responsible for elevating RAE-1 and MCP-1, a macrophage attracting chemokine. Inhibiting STING activation greatly attenuates cardiomyocyte RAE-1 expression, the cardiomyocyte apoptosis, TGF-&#x003b2;1 and fibrosis.</p></sec><sec><title>Conclusion</title><p>Our data highlight a novel pathway by which CD8 T cells contribute to an early triggering mechanism in CF development; preventing CD8+ T cell activation by inhibiting the cardiomyocyte RAE-1-CD8+ T cell-NKG2D axis holds promise for novel therapeutic strategies to limit hypertensive cardiac fibrosis.</p></sec></abstract><kwd-group><kwd>cardiac fibrosis</kwd><kwd>CD8+ T cells</kwd><kwd>perforin</kwd><kwd>NKG2D</kwd><kwd>cardiomyocytes</kwd><kwd>RAE-1</kwd><kwd>STING</kwd><kwd>TGF-&#x003b2;1</kwd></kwd-group><funding-group><award-group><funding-source id="cn001"><institution-wrap><institution>National Health and Medical Research Council
</institution><institution-id institution-id-type="doi">10.13039/501100000925</institution-id></institution-wrap></funding-source></award-group></funding-group><counts><fig-count count="9"/><table-count count="0"/><equation-count count="0"/><ref-count count="69"/><page-count count="19"/><word-count count="6841"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>The accumulation of fibrotic tissue seen as a diffuse increase in collagen fibers accounts for most of the fibrotic remodeling of the heart during hypertension (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>), the most common risk factor for heart failure with preserved ejection fraction (HFpEF) (<xref rid="B3" ref-type="bibr">3</xref>), and a leading cause of death (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). Fibrosis largely accounts for the poor cardiac function in HFpEF, greatly impairing ventricular relaxation; it also increases the frequency of life-threatening arrhythmias (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). Transforming growth factor-beta1 (TGF-&#x003b2;1) is the most important pro-fibrotic cytokine for development of cardiac fibrosis (<xref rid="B8" ref-type="bibr">8</xref>) and exerts its effects by stimulating cardiac fibroblasts to produce collagen (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>). However, despite its importance, neither it nor its receptors are suitable therapeutic targets for fibrosis, as inhibition leads to development of severe autoimmune-like symptoms, a consequence of its many pleiotropic effects (<xref rid="B11" ref-type="bibr">11</xref>).</p><p>Immune cells are also potentially important therapeutic targets with mast cells (<xref rid="B12" ref-type="bibr">12</xref>), macrophages (<xref rid="B13" ref-type="bibr">13</xref>), CD4+ and CD8+ T cells (<xref rid="B14" ref-type="bibr">14</xref>) strongly associated with cardiac fibrosis. Cardiac fibrosis is greatly reduced in TCR-&#x003b1;-/- mice, indicating a critically important role for T cells (<xref rid="B15" ref-type="bibr">15</xref>), but the role of CD8+ T cells in hypertensive cardiac fibrosis remains unclear. Using mice deficient in CD8&#x003b1; chain Laroumanie et&#x000a0;al. concluded that CD8+ T cells were not important for development of cardiac fibrosis (<xref rid="B16" ref-type="bibr">16</xref>). In contrast studies by Ma et al, also using mice deficient in CD8&#x003b1; chain, concluded that CD8+ T cells are critically important for cardiac fibrosis (<xref rid="B17" ref-type="bibr">17</xref>). Furthermore, using MHC class I-restricted OVA-specific TCR transgenic mice, these investigators concluded that CD8+ T cells exert pro-fibrotic effects <italic>via</italic> yet-to-be-defined innate TCR-independent mechanisms (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>).</p><p>In an attempt to resolve this controversy, we chose to examine the effects of targeting CD8&#x003b2; chain rather than the &#x003b1; chain; most CD8+ T cells express a heteromeric CD8 consisting of &#x003b1;- and &#x003b2;-chains (<xref rid="B19" ref-type="bibr">19</xref>). We examined the effects of deleting CD8&#x003b2; chain on cardiac fibrosis in three different hypertensive models: mice with renal hypertension, mice with steroid dependent hypertension and mice with systolic hypertension initiated by aortic constriction. We also define the mechanisms by which CD8+ T cells contribute to hypertensive fibrosis. We initially confirmed the earlier finding of Ma et al (<xref rid="B17" ref-type="bibr">17</xref>) that CD8+ T cells are critical for development of hypertensive cardiac fibrosis and also demonstrated that this profibrotic effect of CD8+ T cells is independent of mechanisms responsible for elevating blood pressure.</p><p>We further extended the earlier finding of Ma et&#x000a0;al. on innate TCR and development of hypertensive cardiac fibrosis (<xref rid="B17" ref-type="bibr">17</xref>), demonstrating that crosstalk between CD8+ T cells and overly stressed cardiomyocytes is critical for development of fibrosis. CD8+ T cells that accumulate in fibrotic heart express the cytotoxin perforin and the innate receptor NKG2D that recognizes stress-induced surface ligands and is sufficient to initiate a killing response (<xref rid="B20" ref-type="bibr">20</xref>). Stressed cardiomyocytes express the NKG2D receptor activating ligand RAE-1 as well as monocyte chemoattractant protein-1 (MCP-1) initiated <italic>via</italic> the cGAS-STING cytosolic DNA sensing pathway. Interaction of NKG2D with RAE-1 activates the cytotoxic functions of CD8+ T cells resulting in killing of overly stressed cardiomyocytes <italic>via</italic> apoptosis, whilst MCP-1 attracts macrophages. Clearance of apoptotic cells by macrophages is known to increase their expression of TGF-&#x003b2;1 (<xref rid="B20" ref-type="bibr">20</xref>) that may initiate the fibrotic process by stimulating collagen production by fibroblasts (<xref rid="B21" ref-type="bibr">21</xref>); we found increased numbers of macrophages expressing TGF-&#x003b2; within fibrotic regions. TGF-&#x003b2;1 by interacting with fibroblasts further amplifies this effect as it positively regulates its own expression (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>).</p><p>Our results uncover an unexpected unique mechanism for development of hypertensive cardiac fibrosis involving specific interactions between innate cytotoxic CD8+ T cells and stressed cardiomyocytes that may lead to development of new therapeutic strategies to prevent hypertensive cardiac fibrosis associated with HFpEF.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and methods</title><sec id="s2_1"><title>Animals, ethics and experiments</title><p>Experiments were approved by the Animal Ethics Committee at the Alfred Research Alliance, Melbourne, Australia. All mice were on a C57BL/6 genetic background. NKG2D knockout (NKG2D<sup>-/-</sup>) mice were from Jackson Laboratory, Bar Harbor, Maine, USA; perforin knockout (pfp<sup>-/-</sup>) mice were from Mark Smyth, Peter MacCallum Cancer Centre, Melbourne, Australia, CD8&#x003b2; knockout mice were from David Davis, Australian National University, Canberra, Australia with approval from Dan Littman, New York School of Medicine, USA and wild-type C57BL/6 mice were from WEHI, Melbourne, Australia. Mixed chimeric mice whose CD8+ T cells were deficient in perforin or NKG2D were generated using our previously published procedure (<xref rid="B24" ref-type="bibr">24</xref>). Briefly, 6-week-old male wildtype C57BL/6 mice were irradiated with 1100 Gy. To generate mixed chimeric mice with perforin-deficiency limited to CD8+ T cells, irradiated mice were transplanted with 5 million mixed bone marrow cells from CD8&#x003b2;-knockout (80%) and perforin-deficient mice (20%); control mice received bone marrow from CD8&#x003b2;-knockout mice (80%) and wild type mice (20%). An identical strategy was used to generate chimeric mice with NKG2D-deficiency limited to CD8+ T cells. Four weeks after transplantation mice were subjected to TAC surgery. Bone marrow reconstitution and specific perforin/NKG2D deficiencies were confirmed by FACS/immunofluorescence.</p><p>Ketamine 80mg/Kg, Xylazine 20mg/Kg and Atropine 0.06mg/Kg (via intraperitoneal injection) were used to induce a short anesthesia for surgical procedures. Hypertension/pressure overload was induced by trans-aortic constriction (TAC) of the thoracic aorta reducing aortic lumen to 0.44mm as previously described by us (<xref rid="B12" ref-type="bibr">12</xref>). In Sham mice the aortic arch was not narrowed. Two-kidney one-clip (2K1C) hypertension was also induced in anaesthetized mice. The left renal artery exposed and a silver clip (120 &#x000b5;m gap) placed around the artery (<xref rid="B25" ref-type="bibr">25</xref>). Sham operated mice did not undergo clipping. For unilateral nephrectomy-DOCA-salt (1K-DOCA-salt) hypertension the left kidney was removed and a deoxycorticosterone acetate (DOCA) pellet (2.4 mg/day, 21 days; Innovative Research of America, USA) implanted subcutaneously (<xref rid="B26" ref-type="bibr">26</xref>). Sham mice did not receive DOCA. These mice were given 0.9% saline as drinking water.</p><p>Blood pressure and left ventricular diastolic function were measured by micromanometry under anaesthesia [ketamine, xylazine and atropine (80/20/0.06 mg/kg i.p.)] whilst mice were ventilated 28 days post-surgeries using a 1.4F Millar microtipped transducer catheter (Millar Instruments, Houston, TX, USA). The Miller catheter was then inserted into the aorta and the aortic blood pressure recorded using a computer and AD Instrument software (AD Instruments, Australia). The catheter was then advanced into the left ventricle to assess left ventricular diastolic function; &#x02013;dp/dt (min), relaxation time constant (<italic>Tau</italic>), and left ventricular end-diastolic pressure (LVEDP) as previously described (<xref rid="B27" ref-type="bibr">27</xref>).</p><p>For CD8+ T cell depletion, the rat anti-mouse CD8&#x003b2; (lyt-3) monoclonal antibody YTS 156.7 prepared from a hybridoma provided by Steve Cobbold, Oxford University, UK. Mice were administered 0.5 mg antibody/mouse/week i.p, for 4 weeks; IgG2b isotype was administered to control mice. CD4+ T cells were depleted using an anti-CD4 monoclonal antibody (GK1.5) 0.3mg/week i.p. and controls were given non-immune IgG2b. For STING inhibition mice were administered H-151 (0.21mg/day i.p.) commencing one day after surgery for 4 weeks; H-151 covalently blocks STING palmitoylation preventing TBK1 activation and STING phosphorylation (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>).</p><p>At the end of experiment, mice were euthanized using the gradual-fill method of carbon dioxide overdose followed by cervical dislocation. However, mice anesthetised for hemodynamic measurements were euthanized <italic>via</italic> cervical dislocation.</p></sec><sec id="s2_2"><title>Flow cytometry</title><p>Flow cytometry was performed as previously described (<xref rid="B24" ref-type="bibr">24</xref>), using APC-conjugated rat anti-mouse CD4 mAb (clone: RM4-5; BD Biosciences), PerCP conjugated anti-mouse CD8&#x003b1; mAb (clone: 53-6.7; BD Biosciences), APC-Cy7conjugated Armenian hamster anti-mouse TCR-&#x003b2; mAb (clone: H57-597; Biolegend) and FITC conjugated rat anti-mouse CD19 antibody (BD Pharmingen). For perforin staining PE conjugated rat anti-mouse perforin (clone: eBioOMAK-D; eBiosciences) was used. For intracellular perforin, spleen cells were stimulated for 12 hours with phorbol 12-myristate 13-acetate, ionomycin, brefeldin A and monensin (eBioscience, San Diego, CA). A BD LSRFortessa was used to acquire flow cytometry data, analysed using BD FACSDiva.</p></sec><sec id="s2_3"><title>Cardiac tissue processing</title><p>The left ventricle (LV) was dissected into three equal transverse LV slices and frozen in OTC at -70&#x000b0;C; 6 &#x000b5;m-thick sections were cut for histology/immunofluorescence stainings and 30 &#x000b5;m-thick sections for ROS assessment.</p></sec><sec id="s2_4"><title>Cardiac fibrosis</title><p>For collagen deposition sections were stained with Picrosirius Red F3BA, (0.1% solution in saturated aqueous picric acid) and analysed using a computer &#x02013;interfaced colour Imaging system (Optimus Bioscan 2. Thomas Optical Measurement System, Inc). Ten randomly selected fields from each section were analysed and expressed as percent of the stained area (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B14" ref-type="bibr">14</xref>).</p></sec><sec id="s2_5"><title>Immunohistochemical staining</title><p>Six &#x000b5;m sections were allowed to thaw then fixed in cold (-20&#x000b0;C) acetone for 20 min. Sections were sequentially incubated in 3% hydrogen peroxide in PBS (20 min), 10% normal serum/PBS (30 min) and biotin/avidin-blocking reagents (15 min each reagent) (Vector Laboratories). These sections were then incubated (1hr) with primary antibodies in serum: rat anti-mouse CD4 (BD: cat#550280), rat anti-mouse CD8 (BD: cat#550281), rat anti-mouse CD68 (BioRad: cat#MCA1957), rabbit anti-mouse TGF&#x003b2;1 (Novus Biological: cat#NB100-91995), or corresponding non-immune IgG&#x02019;s. Then, sections were washed and incubated with the appropriate secondary antibody (biotinylated mouse anti-rat: BD Pharmingen cat#550325 or biotinylated anti-rabbit; Vector Labs: cat#BA-1000)] for 40 min, followed by incubation with streptavidin horseradish peroxidase complex (30 min) (Vector Laboratories) and counterstaining with haematoxylin. Antigens were visualised using 3, 3-diamonobenzidine (Sigma). Cell expressing antigens were quantitated by cell counting in ten randomly selected fields per section.</p></sec><sec id="s2_6"><title>Immunofluorescence</title><p>Sections were fixed in acetone, washed and permeabilized in 0.1% Triton-X-100/PBS. After washings, sections were incubated in 10% normal serum/PBS before being incubated with primary antibodies in serum: rabbit anti-mouse CD8 (Sino Biological: cat#50389-R20), mouse anti-mouse NK1.1 (Biolegend: cat#108701), Armenian Hamster- anti-mouse TCR &#x003b3;/&#x003b4; (Biolegend: cat#108101), rat anti-mouse Perforin (LS Biosciences: cat#LS-C18632), biotin rat anti-mouse NKG2D (R&#x00026;D Systems; cat#BAM1547), rabbit anti-mouse TGF&#x003b2;1 (Novus Biological: cat#NB100-91995), rat anti-mouse CD68 (BioRad: cat#MCA1957), rabbit anti-mouse troponin (Abcam: cat#ab125266), goat anti-mouse RAE-1 (R&#x00026;D Systems: cat#AF1136), rabbit anti-mouse &#x003b1;-Actinin (Acris Antibodies: cat#BP210), rabbit anti-mouse phosphor-STING (Invitrogen: cat# PA5-105674), goat anti-mouse CX3CR1 (R &#x00026; D Systems: cat#AF5825), mouse anti-mouse phospho p38MAPK (Biolegend: cat#690201), rabbit anti-mouse phospho-IRF3 (Cell Signaling: cat#29047), rabbit anti-mouse phospho-TBK1 (Imgenex: cat# IMX-5194), mouse anti-mouse NF-kB (Santa Cruz: cat# sc-109), rabbit anti-mouse MCP-1 (Abcam: cat&#x000a0;#ab7202), rabbit anti-mouse &#x003b1;-Actinin Biotin (Bioss antibodies: cat# BS-10367R-Biotin) or corresponding isotype matched control IgG antibodies. Then sections were then washed and incubated with secondary antibodies/conjugates (goat anti-rat Alexa 488, Invitrogen: cat#A11006; goat anti-rabbit Alexa 488, Invitrogen: cat#A11034; goat anti-rabbit TRITC, Novex: cat# A24542; goat anti-rat TRITC, Novex: cat#A18870; donkey anti-goat TRITC, Invitrogen: cat#A16004 or Streptavidin Alexa 488, Invitrogen: cat#S11223; goat anti-mouse Alexa 488, Invitrogen: cat# A11029; goat anti-rabbit Alexa 568, Invitrogen: cat#A11036 or streptavidin TRITC, Serotec: cat# STAT3B) for 30 min, washed in PBS and counterstained with 4&#x02019;,6-diamidino-2-phenylindole dihydrochloride (DAPI). For dual fluorescence stainings sections were first incubated with the first primary antibody/secondary antibody and after multiple washings were incubated with the second primary antibody and its corresponding secondary antibody. Antigens were assessed using an Olympus BX61 microscope with a FV11 CCD camera using cellSens imaging software (Olympus).</p></sec><sec id="s2_7"><title>TUNEL staining</title><p>Apoptotic cells were identified using a deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) system [<italic>In Situ</italic> Cell Death Detection Kit-POD (Roche: cat#11-684-817-910)]. Briefly, sections were incubated in 4% diethyl pyrocarbonate (DEPC)/100% ethanol at 4C, washed and fixed in acetone. Sections were permeabilized in 0.1% Triton-X-100 and incubated in 15% FCS/2% BSA/0.1M Tris-HCl buffer and after washing, they were incubated with a TUNEL reaction mixture at 37C (according to the manufacturer&#x02019;s instructions), washed and counterstained with DAPI. TUNEL positive cells were visualized using Olympus BX61 microscope. For double immunofluorescence to identify apoptotic cardiomyocytes frozen sections were stained by TUNEL followed by rabbit anti-mouse &#x003b1;-Actinin (Acris Antibodies, Cat#BP210). Then goat anti-rabbit Alexa 568 (Invitrogen, cat#A11036) was used to detect Actinin. Nuclei were counterstained with DAPI and apoptotic cardiomyocytes visualised using a Nikon A1r confocal microscope. Ten randomly selected fields per section were analysed.</p></sec><sec id="s2_8"><title>Cardiomyocyte cytosolic DNA</title><p>Cytosolic DNA and cardiomyocytes were stained with Pico488 (picogreen), a highly sensitive fluorescent dye that can detect double stranded cytoplasmic DNA (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>) and anti-&#x003b1;-Actinin antibody. Six &#x000b5;m formalin-fixed permeabilized sections of left ventricle were incubated with Pico488 DNA quantification solution (Lumiprobe, Cat#12010) followed by polyclonal rabbit anti-mouse &#x003b1;-Actinin antibody (see above). Then goat anti-rabbit Alexa 568 secondary antibody (see above) was used to detect Actinin. After counterstaining with DAPI the sections were visualised using a Nikon A1r confocal microscope.</p></sec><sec id="s2_9"><title>Reactive oxygen species</title><p>Reactive oxygen species (ROS) were measured using dihydroethidium (DHE). Sections were incubated with DHE (10 &#x003bc;M, Krebs bicarbonate buffer), protected from light at 37&#x000b0;C for 30 min. Images were obtained using a fluorescence microscope measuring fluorescence <italic>via</italic> a 585 nm long-pass filter (<xref rid="B12" ref-type="bibr">12</xref>).</p></sec><sec id="s2_10"><title>Statistical analysis</title><p>Randomized and coded animals and samples were processed and analyzed by blinded investigators. All data was analyzed statistically using Prism 8.0 (GraphPad Software, La Jolla, CA, USA). All results are expressed as man &#x000b1; SEM. <italic>n</italic> represents mouse numbers in each experiment, as detailed in figure legends. Comparison between two groups were determined by two-tailed Student&#x02019;s <italic>t-</italic>test, and three or more groups were compared by one-way ANOVA followed by Tukey-Kramer <italic>post hoc</italic> analysis. <italic>P &#x0003c;</italic> 0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec id="s3_1"><title>CD8+ T cells are critical for hypertensive cardiac interstitial fibrosis irrespective of hypertension etiology</title><p>We used three different hypertensive mouse models to assess the importance of CD8+ T cells for development of cardiac fibrosis: 1) mice whose systolic blood pressure is elevated by trans-aortic constriction (TAC) inducing left ventricular pressure overload 2) mice with high-renin salt-independent 2K1C renovascular hypertension and 3) mice with salt-sensitive low-renin deoxycorticosterone (DOCA)-salt hypertension. We used highly specific anti-CD8&#x003b2; antibodies to deplete CD8&#x003b1;&#x003b2;+ T (CD8+ T) cells (<xref rid="B32" ref-type="bibr">32</xref>). Their depletion during the 4-week study period reduced ventricular CD8+ T cells in all three models (<xref rid="f1" ref-type="fig">
<bold>Figures&#x000a0;1A</bold>
</xref>, <xref rid="SF1" ref-type="supplementary-material">
<bold>S1A, G</bold>
</xref>). Compared to normotensive sham-operated mice (Systolic Blood Pressure (SBP) = 103 &#x000b1; 5 mmHg; n=10), mice subjected to TAC, 2K1C or DOCA procedure were hypertensive (<xref rid="f1" ref-type="fig">
<bold>Figures&#x000a0;1B</bold>
</xref>, <xref rid="SF1" ref-type="supplementary-material">
<bold>S1B, H</bold>
</xref>). Neither hypertension (<xref rid="f1" ref-type="fig">
<bold>Figures&#x000a0;1B</bold>
</xref>, <xref rid="SF1" ref-type="supplementary-material">
<bold>S1B, H</bold>
</xref>), left ventricular hypertrophy (<xref rid="f1" ref-type="fig">
<bold>Figures&#x000a0;1C</bold>
</xref>, <xref rid="SF1" ref-type="supplementary-material">
<bold>S1C, I</bold>
</xref>) nor cardiac CD4+ T cells were affected (<xref rid="f1" ref-type="fig">
<bold>Figure&#x000a0;1D</bold>
</xref>) but left ventricular fibrosis was significantly reduced (<xref rid="f1" ref-type="fig">
<bold>Figures&#x000a0;1E</bold>
</xref>, <xref rid="SF1" ref-type="supplementary-material">
<bold>S1D, S1J</bold>
</xref>). As fibrosis is associated with poor cardiac function due to impaired ventricular relaxation, we also assessed using micromanometry how CD8+ T cell depletion affected left ventricular diastolic function and relaxation (<xref rid="B33" ref-type="bibr">33</xref>). CD8+ T cell depletion greatly improved left ventricular relaxation (-dp/dt) and reduced isovolumic relaxation constant (tau) and left ventricular end diastolic pressure (LVEDP) (<xref rid="f1" ref-type="fig">
<bold>Figures&#x000a0;1F</bold>
</xref>, <xref rid="SF1" ref-type="supplementary-material">
<bold>S1E, K</bold>
</xref>). Since CD8+ T cells can be cytotoxic, we assessed effects on apoptotic cells. CD8+ T Cell depletion reduced cardiac apoptotic cell numbers by 70-79% (<xref rid="f1" ref-type="fig">
<bold>Figures&#x000a0;1G</bold>
</xref>, <xref rid="SF1" ref-type="supplementary-material">
<bold>S1F, L</bold>
</xref>). As macrophages are also important for fibrosis (<xref rid="B34" ref-type="bibr">34</xref>), and known to remove apoptotic cells by phagocytosis (<xref rid="B35" ref-type="bibr">35</xref>), thus increasing their biosynthesis of TGF-&#x003b2;1 (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B21" ref-type="bibr">21</xref>), we also assessed macrophage TGF-&#x003b2;1 expression in the TAC mice. TGF-&#x003b2;1-positive macrophages were most apparent in fibrotic regions and greatly reduced following CD8+ T cell depletion (<xref rid="f1" ref-type="fig">
<bold>Figure&#x000a0;1H</bold>
</xref>). These findings indicate that TGF-&#x003b2;1 produced by macrophages is an early signaling event; this TGF-&#x003b2;1, by activating fibroblasts to produce collagen can further elevate TGF-&#x003b2;1 levels by positively regulating its own expression in fibroblasts (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B22" ref-type="bibr">23</xref>), greatly increasing the pro-fibrotic signal. To determine whether the CD8+ T cells exhibited a memory phenotype, we assessed their expression of CX<sub>3</sub>CR1. The majority of CD8+ T cells in fibrotic areas of TAC hearts expressed CX<sub>3</sub>CR1 (<xref rid="f1" ref-type="fig">
<bold>Figure&#x000a0;1I</bold>
</xref>), consistent with a memory CD8+ T cell subset that possesses less proliferative ability, but higher cytotoxic effector function (<xref rid="B36" ref-type="bibr">36</xref>). Given the commonality between cardiac fibrosis, CD8+ T cells and cardiac apoptosis in the different hypertensive mice, we focused our subsequent mechanistic studies only on TAC mice.</p><fig position="float" id="f1"><label>Figure&#x000a0;1</label><caption><p>CD8+ T cells promote hypertension-induced cardiac fibrosis. <bold>(A)</bold> Representative photomicrographs of CD8+ T cells within the left ventricle (LV) of hypertensive TAC mice and their depletion using anti-CD8&#x003b2; antibodies. <bold>(B)</bold> Systolic aortic blood pressures (SBP) recorded in aortas by micromanometry and <bold>(C)</bold> LV hypertrophy measured as wall plus septum/body weight (LVS/BW) ratio in TAC mice with/without CD8&#x003b1;&#x003b2;+ T cells. <bold>(D)</bold> CD4+ T cells in LV are unaffected by CD8&#x003b1;&#x003b2;+ T cell depletion. <bold>(E)</bold> Photomicrographs showing the reduction in LV fibrosis in TAC mice associated with CD8&#x003b1;&#x003b2;+ T cell depletion. <bold>(F)</bold> Effects of CD8&#x003b1;&#x003b2;+ T cell depletion on LV diastolic function (-dp/dt, Tau and LVEDP) measured by micromanometry. <bold>(G)</bold> Photomicrographs showing reductions in TUNEL+ (apoptotic) cells in LV following CD8&#x003b1;&#x003b2;+ T cell depletion. <bold>(H)</bold> Photomicrographs depicting effects of CD8&#x003b1;&#x003b2;+ T cell depletion on CD68+ macrophages expressing TGF-&#x003b2;1 in LV of TAC mice. <bold>(I)</bold> Photomicrographs showing CD8+ T cells accumulated in TAC left ventricle expressing CX3CR1. Results are means &#x000b1; SEM with small circles representing data from individual mice. n=6-12/group. PSR; picrosirius red, -ve control; no primary antibody control, sham; sham-operated, scale bar represents 50&#x000b5;m. *P &#x0003c; 0.05 using two-tailed Student&#x02019;s t-test or one-way ANOVA comparing to TAC-IgG.</p></caption><graphic xlink:href="fimmu-13-1040233-g001" position="float"/></fig></sec><sec id="s3_2"><title>CD4+ T cells are required for optimum cardiac CD8+ T cell profibrotic activity</title><p>As CD4+ T cells contribute to development of cardiac fibrosis (<xref rid="B16" ref-type="bibr">16</xref>), we examined whether CD4+ T cells provide help to CD8+ T cells. CD8+ T cells initiating low inflammatory responses are known to be highly dependent on CD4+ T cell help (<xref rid="B37" ref-type="bibr">37</xref>). We depleted CD4+ T cells in TAC mice using anti-CD4 cell depleting antibodies and 28 days later examined effects on CD8+ T cells and pro-fibrotic responses. Treatment with depleting antibodies reduced spleen CD4+ cell numbers by approximately 95% without effecting CD8+ cells (<xref rid="f2" ref-type="fig">
<bold>Figure&#x000a0;2A</bold>
</xref>). In contrast cardiac CD8+ T cells were reduced by 55% (<xref rid="f2" ref-type="fig">
<bold>Figure&#x000a0;2B</bold>
</xref>) and fibrosis by 60% (<xref rid="f2" ref-type="fig">
<bold>Figure&#x000a0;2C</bold>
</xref>); apoptotic cell numbers were also reduced, by 45% (<xref rid="f2" ref-type="fig">
<bold>Figure&#x000a0;2D</bold>
</xref>). Cardiac macrophage numbers were reduced (<xref rid="f2" ref-type="fig">
<bold>Figure&#x000a0;2E</bold>
</xref>), as were cells expressing TGF-&#x003b2;1 (<xref rid="f2" ref-type="fig">
<bold>Figure&#x000a0;2F</bold>
</xref>). These findings indicate that CD4+ T cells enhance the profibrotic actions of CD8+ T cells, mostly likely by increasing their survival (<xref rid="B38" ref-type="bibr">38</xref>).</p><fig position="float" id="f2"><label>Figure&#x000a0;2</label><caption><p>CD8+ T cells require help from CD4+ T cell in promoting cardiac fibrosis. <bold>(A)</bold> Representative FACS plots showing treatment of TAC mice with anti-CD4 antibodies depletes spleen CD4+ cells without affecting CD8+ cells controls. <bold>(B)</bold> Depletion of CD4+ T cells significantly reduces ventricular CD8+ T numbers compared to controls during fibrosis in TAC mice. <bold>(C)</bold> LV fibrosis staining is greatly reduced following CD4+ T cell depletion in TAC mice. <bold>(D)</bold> TUNEL+ cells are reduced by CD4+ T cell depletion in TAC mice. <bold>(E)</bold> CD68+ macrophage numbers are reduced with CD4+ T cell depletion. <bold>(F)</bold> Numbers of TGF-&#x003b2;1 expressing cells in LV are reduced with anti-CD4 antibody treatment. Results are means &#x000b1; SEM with small circles representing data from individual mice. n=4-9/group. PSR; picrosirius red, -ve control; no primary antibody control, scale bar represents 50&#x000b5;m. *P&#x0003c; 0.05 using two-tailed Student&#x02019;s t-test one-way ANOVA comparing to TAC-IgG.</p></caption><graphic xlink:href="fimmu-13-1040233-g002" position="float"/></fig></sec><sec id="s3_3"><title>Profibrotic effects of CD8+ T cells are dependent on the cytotoxin perforin and innate NKG2D receptor</title><p>Given the relationship between CD8+ T cells and cardiac apoptotic cells and the earlier proposal suggesting that CD8+ T cells promote fibrosis <italic>via</italic> innate mechanisms (<xref rid="B17" ref-type="bibr">17</xref>), we examined whether cardiac CD8+ T cells were cytotoxic and expressed innate NKG2D receptors; NKG2D receptors recognize stress-induced surface ligands and are sufficient to initiate a killing response (<xref rid="B39" ref-type="bibr">38</xref>). The majority of the CD8+ T cells in ventricular fibrotic areas expressed perforin (<xref rid="f3" ref-type="fig">
<bold>Figure&#x000a0;3A</bold>
</xref>) and NKG2D (<xref rid="f4" ref-type="fig">
<bold>Figure&#x000a0;4A</bold>
</xref>) in TAC mice. To determine if perforin was required for fibrosis, we generated mixed chimeric (CD8T-Pfp<sup>-/-</sup>) mice in which CD8+ T cells were made deficient in perforin (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B39" ref-type="bibr">39</xref>), transferring mixed bone marrow [80% from CD8&#x003b2;-deficient and 20% from perforin-deficient mice] into irradiated C57BL/6 mice; control (CD8T-Pfp<sup>+/+</sup>) mice received mixed bone marrow from CD8&#x003b2;-deficient (80%) and 20% from wild type mice (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B39" ref-type="bibr">39</xref>). In these mice CD8+ T cells are derived from bone marrow of either the perforin-deficient or wild type mice. Four weeks after bone marrow transplantation major lymphocyte populations in the spleen were comparable to those in non-irradiated C57BL/6 mice (<xref rid="f3" ref-type="fig">
<bold>Figure&#x000a0;3B</bold>
</xref>). FACS analysis confirmed that in CD8T-Pfp<sup>-/-</sup> mice, TCR&#x003b2;+ CD8+ T cells did not express perforin (<xref rid="f3" ref-type="fig">
<bold>Figure&#x000a0;3C</bold>
</xref>). Mixed chimeric mice were subjected to TAC surgery and effects on cardiac fibrosis examined 4-weeks later. Cardiac fibrosis was nearly abolished in mice with perforin-deficient CD8+ T cells (<xref rid="f3" ref-type="fig">
<bold>Figure&#x000a0;3D</bold>
</xref>). Also cardiomyocyte apoptosis was markedly attenuated (<xref rid="f3" ref-type="fig">
<bold>Figure&#x000a0;3E</bold>
</xref>). We assessed effects on ventricular macrophages and TGF-&#x003b2;1. Both macrophages and TGF-&#x003b2;1 were greatly reduced when perforin is deleted from CD8+ T cells (<xref rid="f3" ref-type="fig">
<bold>Figures&#x000a0;3F, G</bold>
</xref>). In accordance with these findings, previous studies have reported that macrophages are the major apoptotic cell-clearing phagocytes in tissue homeostasis (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>) and their production of TGF-&#x003b2;1 is increased following phagocytosis of apoptotic cells (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B42" ref-type="bibr">42</xref>). To assess the importance of NKG2D we also generated mixed chimeric mice using bone marrow from CD8&#x003b2;-deficient, NKG2D-deficient and wild type mice and subjected the mice to TAC surgery. We confirmed that cardiac CD8+ T cells in hearts of chimeric mice did not express NKG2D (<xref rid="f4" ref-type="fig">
<bold>Figure&#x000a0;4B</bold>
</xref>), however, NK/NKT and TCR&#x003b3;&#x003b4;+ T cells accumulated in myocardial fibrotic areas expressed NKG2D receptor in TAC mice with NKG2D deficiency limited to CD8 T cells (<xref rid="SF2" ref-type="supplementary-material">
<bold>Figure S2</bold>
</xref>). Cardiac fibrosis in these mice was nearly abolished (<xref rid="f4" ref-type="fig">
<bold>Figure&#x000a0;4C</bold>
</xref>); apoptotic cardiomyocytes were greatly reduced (<xref rid="f4" ref-type="fig">
<bold>Figure&#x000a0;4D</bold>
</xref>) as were macrophage numbers and TGF-&#x003b2;1 expressing cells (<xref rid="f4" ref-type="fig">
<bold>Figures&#x000a0;4E, F</bold>
</xref>). These findings indicate that CD8+ T cells are activated locally within the left ventricle by mechanisms dependent on the NKG2D receptor and use perforin to promote fibrosis.</p><fig position="float" id="f3"><label>Figure&#x000a0;3</label><caption><p>Cardiac CD8+ T cells require perforin to promote fibrosis. <bold>(A)</bold> Representative photomicrographs indicating perforin expression by CD8+ T cells in fibrotic ventricle of TAC mice. <bold>(B)</bold> Bar graphs indicating that 4-weeks after bone marrow transplantation major lymphocyte populations have recovered to levels seen in non-irradiated C57BL/6 mice. <bold>(C)</bold> Representative FACS plots indicating that spleen CD8+ T cells in CD8T-Pfp<sup>-/-</sup> mice are deficient in perforin 4 weeks after BMT compared to CD8T-Pfpf<sup>+/+</sup> mice. <bold>(D)</bold> Photomicrographs (PSR) together with mean data indicating that perforin deletion in CD8+ T cells attenuates fibrosis in LV of TAC mice compared to controls. <bold>(E)</bold> Photomicrographs indicating that TUNEL+Actinin+ cardiomyocytes are greatly reduced in mice with perforin deficient CD8+ T cells. <bold>(F)</bold> LV CD68+ macrophages and <bold>(G)</bold> TGF-&#x003b2;1 expressing cells are greatly reduced with perforin deletion from CD8+ T cells. Results are means &#x000b1; SEM with small circles representing data from individual mice. n=5-9/group. PSR; picrosirius, -ve control; no primary antibody control, sham; sham-operated, scale bar represents 50&#x000b5;m. *P&#x0003c; 0.05 using two-tailed Student&#x02019;s t-test comparing to CD8T-Pfp<sup>+/+</sup>.</p></caption><graphic xlink:href="fimmu-13-1040233-g003" position="float"/></fig><fig position="float" id="f4"><label>Figure&#x000a0;4</label><caption><p>Cardiac CD8+ T cells require NKG2D receptors to promote fibrosis. <bold>(A)</bold> Photomicrographs indicating that CD8+ cells accumulated in LV of TAC mice express NKG2D receptor. <bold>(B)</bold> CD8+ T cells of TAC mice that underwent bone marrow transplantation with mixed bone marrow deficient in NKG2D (CD8T-NKG2D<sup>-/-</sup>) do not express NKG2D compared to controls (CD8T-NKG2D<sup>+/+</sup>). <bold>(C)</bold> LV fibrosis is attenuated in TAC mice with NKG2D-deficient CD8+ T cells. <bold>(D)</bold> TUNEL+ Actinin+ cardiomyocytes are greatly reduced in mice with NKG2D-deficient CD8+ T cells. <bold>(E, F)</bold> LV CD68+ macrophages and TGF-&#x003b2;1 expressing cells in TAC mice with NKG2D-deficient CD8+ T cells are markedly reduced. Results are means &#x000b1; SEM with small circles representing data from individual mice. n=7-9/group. PSR; picrosirius, -ve control; no primary antibody control, scale bar represents 50&#x000b5;m. *P&#x0003c; 0.05 using two tailed Student&#x02019;s t-test comparing to CD8T-NKG2D<sup>+/+</sup>.</p></caption><graphic xlink:href="fimmu-13-1040233-g004" position="float"/></fig></sec><sec id="s3_4"><title>Cardiomyocyte RAE-1 and MCP-1 are increased <italic>via</italic> the cGAS-STING cytosolic DNA sensing pathway triggering CD8+ T cell cytotoxicity and interstitial fibrosis</title><p>We have previously shown that during development of cardiac fibrosis reactive oxygen species (ROS) are greatly increased (<xref rid="B12" ref-type="bibr">12</xref>). Increases in ROS promote mitochondrial DNA damage and its leakage into the cytoplasm (<xref rid="B43" ref-type="bibr">43</xref>) thus activating the cytoplasmic STING-TBK1-IRF3-IFN-&#x003b2; signaling pathway (<xref rid="B44" ref-type="bibr">44</xref>). As RAE-1 ligands which activate the NKG2D receptor are regulated <italic>via</italic> IRF3 (<xref rid="B45" ref-type="bibr">45</xref>), we investigated whether cardiac RAE-1 and the cGAS-STING pathway might be important for CD8+ T cell mediated interstitial fibrosis in the hypertensive heart. We confirm that high ROS levels in hypertensive hearts (<xref rid="f5" ref-type="fig">
<bold>Figure&#x000a0;5A</bold>
</xref>) and using fluorescent DNA binding molecule pico488 (PicoGreen) (<xref rid="B46" ref-type="bibr">46</xref>), demonstrate the presence of cytosolic DNA in cardiomyocytes of hypertensive hearts (<xref rid="f5" ref-type="fig">
<bold>Figure&#x000a0;5B</bold>
</xref>). Cardiomyocyte RAE-1 was also greatly elevated (<xref rid="f5" ref-type="fig">
<bold>Figure&#x000a0;5C</bold>
</xref>); similarly, phosphoSTING was detectable in stressed cardiomyocytes (<xref rid="f5" ref-type="fig">
<bold>Figure&#x000a0;5D</bold>
</xref>), indicating cGAS-STING DNA sensor pathway activation (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>). To determine whether this pathway was responsible for the RAE-1 expression, CD8+ T cell mediated apoptosis and fibrosis we treated TAC mice with H-151, a small molecule inhibitor that blocks STING plamitoylation, which is required for STING signaling (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B47" ref-type="bibr">47</xref>). Treatment inhibited cardiac STING signaling, indicated by the absence of phosphoSTING (<xref rid="f5" ref-type="fig">
<bold>Figure&#x000a0;5E</bold>
</xref>); treatment also prevented RAE-1 expression (<xref rid="f5" ref-type="fig">
<bold>Figure&#x000a0;5F</bold>
</xref>) and cardiac cell apoptosis (<xref rid="f6" ref-type="fig">
<bold>Figure&#x000a0;6A</bold>
</xref>), resulting in reduced cardiac fibrosis (<xref rid="f6" ref-type="fig">
<bold>Figure&#x000a0;6B</bold>
</xref>). Macrophages and TGF-&#x003b2;1 expressing cells were also greatly reduced (<xref rid="f6" ref-type="fig">
<bold>Figures&#x000a0;6C, D</bold>
</xref>). Neither left ventricular hypertrophy nor blood pressure were affected (<xref rid="f6" ref-type="fig">
<bold>Figures&#x000a0;6E, F</bold>
</xref>); left ventricular micromanometry indicated markedly improved left ventricular relaxation and diastolic function in H-151 treated mice (<xref rid="f6" ref-type="fig">
<bold>Figure&#x000a0;6G</bold>
</xref>).</p><fig position="float" id="f5"><label>Figure&#x000a0;5</label><caption><p>Cytosolic DNA and STING in stressed cardiomyocytes initiates the fibrotic signaling cascade. <bold>(A)</bold> Representative photomicrographs demonstrating increases in ROS in LV of TAC mice. <bold>(B)</bold> Photomicrographs demonstrating increases in cytosolic DNA in cardiomyocytes of TAC mice detected with Pico488. Representative photomicrographs demonstrating increases in RAE-1 expression in cardiomyocytes <bold>(C)</bold> together with increased phosphoSTING <bold>(D)</bold> during TAC-induced hypertension. Treatment with H-151, anti-STING small molecular inhibitor, reducesphosphoSTING expression <bold>(E)</bold> and prevents cardiomyocyte expression of RAE-1 expression <bold>(F)</bold> in LV of TAC mice. Results are means &#x000b1; SEM with small circles representing data from individual mice. n=7-9/group. -ve control; no primary antibody control, sham; sham-operated, scale bar represents either 100&#x000b5;m or 50&#x000b5;m. *P&#x0003c;0.05 using two tailed Student&#x02019;s t-test test comparing to either TAC or H-151.</p></caption><graphic xlink:href="fimmu-13-1040233-g005" position="float"/></fig><fig position="float" id="f6"><label>Figure&#x000a0;6</label><caption><p>H-151, small molecule STING inhibitor, reduces cardiac fibrosis and improves left ventricular (LV) diastolic function. H-151 treatment markedly reduces <bold>(A)</bold> LV cell apoptosis and <bold>(B)</bold> LV fibrosis (PSR staining) in TAC mice. <bold>(C)</bold> LV CD68+ macrophages and <bold>(D)</bold> cells expressing TGF-&#x003b2;1 are greatly reduced in H-151 treated mice. <bold>(E)</bold> LV hypertrophy (LVS/BW) and <bold>(F)</bold> systolic blood pressure (SBP) are not affected by H-151 treatment. <bold>(G)</bold> LV diastolic function is improved by H-151 treatment. Results are means &#x000b1; SEM with small circles representing data from individual mice. n=7-9/group. -ve control; no primary antibody control, scale bar represents 50&#x000b5;m *P&#x0003c; 0.05 using two tailed Student&#x02019;s t-test, comparing to H-151.</p></caption><graphic xlink:href="fimmu-13-1040233-g006" position="float"/></fig></sec><sec id="s3_5"><title>H-151, small molecular anti-STING inhibitor, attenuates TBK-IRF3-NFkB signaling pathway</title><p>To confirm involvement of the STING, TBK-IRF3-NFkB signaling cascade we assessed the phosphorylation status of these molecules in relation to their intracellular location within cardiomyocytes. Phospho-TBK was apparent, localized in the perinuclear region (<xref rid="f7" ref-type="fig">
<bold>Figure&#x000a0;7A</bold>
</xref>), whilst phospho-IRF3 appeared mostly nuclear (<xref rid="f7" ref-type="fig">
<bold>Figure&#x000a0;7B</bold>
</xref>), as was NF-kB (<xref rid="f7" ref-type="fig">
<bold>Figure&#x000a0;7C</bold>
</xref>) and phospho-p38 MAPK (<xref rid="f8" ref-type="fig">
<bold>Figure&#x000a0;8A</bold>
</xref>). Because NF-kB and p38MAPK have been associated with increased MCP-1 (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B49" ref-type="bibr">49</xref>), a chemokine that not only attracts macrophages but also enhances their phagocytic activity (<xref rid="B50" ref-type="bibr">50</xref>), we examined its expression in cardiomyocytes. MCP-1 was increased during development of fibrosis and completely prevented by treatment with H-151 (<xref rid="f8" ref-type="fig">
<bold>Figure&#x000a0;8B</bold>
</xref>) as were all other phosphorylation signals in the TBK-IRF3-NF-kB signaling cascade (<xref rid="f7" ref-type="fig">
<bold>Figures&#x000a0;7</bold>
</xref>, <xref rid="f8" ref-type="fig">
<bold>8A</bold>
</xref>); STING signaling was not apparent in macrophages associated with fibrosis (<xref rid="f8" ref-type="fig">
<bold>Figure&#x000a0;8C</bold>
</xref>).</p><fig position="float" id="f7"><label>Figure&#x000a0;7</label><caption><p>STING-IRF3-NF&#x00138;B signaling cascade is activated in cardiomyocytes during hypertensive fibrosis in TAC mice. <bold>(A)</bold> PhosphoTBK is increased in cardiomyocytes during fibrosis and prevented by H-151. <bold>(B)</bold> Nuclear phosphoIRF3 is increased in cardiomyocytes during fibrosis and inhibited by H-151. <bold>(C)</bold> Nuclear accumulation of NF-&#x00138;B(p65) is increased during fibrosis and inhibited by H-151. Results are means &#x000b1; SEM with small circles represent data from individual mice. n=5-7/group. -ve control; no primary antibody control, scale bar represents 50&#x000b5;m. *P&#x0003c; 0.05 using two tailed Student&#x02019;s t-test, comparing to H-151.</p></caption><graphic xlink:href="fimmu-13-1040233-g007" position="float"/></fig><fig position="float" id="f8"><label>Figure&#x000a0;8</label><caption><p>Cardiac phospho-p38MAPK and MCP-1 are upregulated in hypertensive cardiac fibrosis. <bold>(A)</bold> Nuclear phospho-p38MAPK is increased in cardiomyocytes during fibrosis development and inhibited by H-151. <bold>(B)</bold> Cardiomyocyte MCP-1 expression is increased during fibrosis development and prevented by H-151. <bold>(C)</bold> Macrophages associated with cardiac fibrosis do not express phosphoSTING or phosphoTBK1. Results are means &#x000b1; SEM with small circles represent data from individual mice. n=5-7/group. -ve control; no primary antibody control, scale bar represents 50&#x000b5;m. *P&#x0003c; 0.05 from control TAC mice treated with vehicle only using two tailed Student&#x02019;s t-test, comparing to H-151.</p></caption><graphic xlink:href="fimmu-13-1040233-g008" position="float"/></fig></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>We show for the first time that two signals, one from overly stressed cardiomyocytes and the other from cytotoxic CD8+ T cells are required for development of hypertensive cardiac fibrosis; this interaction between the two cell types is critical for fibrosis. CD8+ T cells in the hypertensive heart appear to have a memory phenotype and are activated <italic>via</italic> interactions between NKG2D receptors expressed by the CD8+ T cells and RAE-1, the NKG2D ligand expressed by stressed cardiomyocytes. Bystander activation of CD8+ T cells is very common during viral infections (<xref rid="B51" ref-type="bibr">51</xref>) but here we show that it is also essential for initiation and development of hypertensive cardiac fibrosis. Fibrosis alters the cardiac electrical conduction system resulting in many deadly arrhythmias; it also increases ventricular stiffness which impairs cardiac function, thereby contributing to heart failure (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>).</p><p>Given that cardiomyocyte apoptosis is a frequent occurrence during hypertension in humans and mice (<xref rid="B52" ref-type="bibr">52</xref>&#x02013;<xref rid="B54" ref-type="bibr">54</xref>), we hypothesized that overly stressed cardiomyocytes in hypertrophied hearts undergo apoptosis and as lost cardiomyocytes cannot be replaced, this will result in fibrosis. Indeed, we found that overly stressed cardiomyocytes initiate a cGAS-STING mediated signaling cascade resulting in RAE-1 expression which activates cytotoxic CD8+ T cells, thus initiating cardiomyocyte apoptosis which in turn activates macrophages and increases their expression of TGF-&#x003b2;1 (<xref rid="B21" ref-type="bibr">21</xref>). This notion explains why the genetic depletion of CD8+ T cells reduces cardiac fibrosis and heart failure in mice with pressure overload despite an initial macrophage accumulation (<xref rid="B55" ref-type="bibr">55</xref>). CD8+ T cells seem to recruit monocyte/macrophages and modulate them into cardioprotective phenotypes to maintain homeostasis before the commencement of myocardial stress (<xref rid="B55" ref-type="bibr">55</xref>). The interaction of TGF-&#x003b2;1 with cardiac fibroblasts stimulates collagen production resulting in fibrosis in hypertensive hearts (<xref rid="B56" ref-type="bibr">56</xref>). Whilst the amount of TGF-&#x003b2; produced by macrophages appears relatively small, TGF-&#x003b2;1 positively regulates its own expression and by interacting with fibroblasts greatly augments the TGF-&#x003b2;1 fibrotic signal (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>). Our study identifies the RAE-1/NKG2D interaction as a novel therapeutic target to prevent the gradual loss of cardiomyocytes in hypertensive hearts due to apoptosis and the cardiac fibrosis associated with HFpEF in hypertensive patients.</p><p>The mechanisms that initiate cardiac fibrosis in non-ischemic hearts are poorly defined. It has been suggested that dying cardiomyocytes release DAMPs which interact with pattern recognition receptors, in particular Toll-like receptors (TLRs) expressed by neighboring cardiomyocytes, fibroblasts, immune cells and parenchymal cells to initiate fibrosis (<xref rid="B43" ref-type="bibr">43</xref>); fibroblasts, macrophages and CD4+ T cells all contribute to cardiac fibrosis that develops in non-ischemic hypertensive hearts (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B56" ref-type="bibr">56</xref>). Whilst multiple DAMPs are released by dying cardiomyocytes, particularly after myocardial infarction and include mitochondrial DNA (mtDNA), the chromatin protein high mobility group box 1 (HMGB1) and S100 proteins, their precise roles in fibrosis are still unclear (<xref rid="B57" ref-type="bibr">57</xref>). Exosomes derived from doxorubicin damaged cardiomyocytes can augment fibrosis but their relevance to non-ischemic hearts is also unclear (<xref rid="B58" ref-type="bibr">58</xref>). We demonstrate that an increase in cytosolic DNA in overly stressed cardiomyocytes is a key early event in fibrosis of non-ischaemic hypertensive hearts; this was confirmed by our demonstration of activation of the cGAS-STING cytosolic DNA sensing pathway. Activating this pathway in cardiomyocytes greatly increases expression of RAE-1, an NKG2D receptor ligand that is absent in non-stressed healthy cells and only induced upon cellular stress (<xref rid="B59" ref-type="bibr">59</xref>). RAE-1 expression was highly dependent on STING activation; RAE-1, an IRF3 responsive gene has previously been shown to be regulated by the STING-dependent DNA sensor pathway in lymphomas (<xref rid="B45" ref-type="bibr">45</xref>). We did not identify the source of the DNA but given the high levels of oxidative stress associated with the hypertensive hearts, it most likely represents mtDNA. We were not able to test this directly <italic>in vivo</italic> as cyclosporin A, which inhibits mitochondrial permeability transition (MPT) pore opening and mtDNA release (<xref rid="B60" ref-type="bibr">60</xref>), also inhibits CD8+ T cell activation (<xref rid="B61" ref-type="bibr">61</xref>). High ROS levels trigger MPT pore opening, resulting in release of mtDNA into the cytosol (<xref rid="B60" ref-type="bibr">60</xref>). Recently Hu et&#x000a0;al. have also shown that deletion of the cytosolic DNA sensor cGAS contributes to cardiac pathology in mice with pressure overload-induced hypertension (<xref rid="B62" ref-type="bibr">62</xref>) but downstream signaling events responsible for cardiac pathology were not investigated; cGAS can have both STING-dependent and independent effects (<xref rid="B63" ref-type="bibr">63</xref>). Accumulation of OVA-specific CD8+ T cells in pressure overload-induced myocardium did not affect cardiac fibrosis (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>), suggesting the importance of their TCR-independent contribution in cardiac fibrosis. Our studies indicate that cytosolic DNA, acting as an intracellular DAMP initiates an inflammatory cascade by stimulating expression of RAE-1 there by activating NKG2D+CD8+ T cells and subsequent cellular/molecular signaling cascade resulting in fibrosis.</p><p>Our findings that depletion of CD8+ T cells reduced cardiac fibrosis independently of the etiology of the hypertension stimulated us to investigate in detail how these cells contributed to fibrosis. Previous studies utilizing CD8&#x003b1; chain genetic deletion have led to conflicting results indicating either a major role or no role in cardiac fibrosis associated with hypertensive hearts (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>). We focused on targeting CD8&#x003b2; chain with specific antibodies and also <italic>via</italic> genetic deletion and have previously used such a strategy to define the role of CD8+ T cells in atherosclerosis (<xref rid="B32" ref-type="bibr">32</xref>). We provide four independent lines of evidence that unequivocally demonstrate that CD8+ T cells are critical for cardiac fibrosis. Depleting CD8+ T cells using anti-CD8&#x003b2; antibodies greatly attenuated cardiac fibrosis in three different hypertensive mouse models indicating that it affects fibrosis independently of hypertension etiology. Furthermore, preventing help from CD4+ T cells markedly reduces CD8+ T cell numbers and fibrosis, effects consistent with the requirement of CD4+ T cells for many aspects of CD8+ T cell function, including their survival (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>) and generation of a cytotoxic phenotype (<xref rid="B64" ref-type="bibr">64</xref>). CD8+ T cells numbers in fibrotic regions were highly dependent on the presence of CD4+ T cells and the majority of CD8+ T cells expressed perforin. Perforin is essential for cell-mediated cytotoxicity enabling granzymes to enter target cells and induce apoptosis. Perforin deletion in CD8+ T cells greatly reduced cardiomyocyte apoptosis, TGF-&#x003b2;1 expression and cardiac fibrosis. Deletion of NKG2D in CD8+ T cells, which is critical for RAE-1 mediated CD8+ T cell activation had similar effects. Together these findings demonstrate a major role for cytotoxic CD8+ T cells in cardiac fibrosis (<xref rid="f9" ref-type="other">Graphical Abstract</xref>).</p><p>Treatments for HFpEF have limited efficacy and currently no drugs have been approved for the treatment of cardiac fibrosis. Experimentally, all currently proposed therapeutic strategies are focused on downstream rather than initiating events (<xref rid="B65" ref-type="bibr">65</xref>) and include cytokines, particularly TGF-&#x003b2;1, as well as targeting different cell types including fibroblasts and macrophages. TGF-&#x003b2; inhibitors are effective but toxic (<xref rid="B65" ref-type="bibr">65</xref>); similarly, the use of engineered T cells to destroy collagen producing fibroblasts although effective is also limited by toxicity (<xref rid="B56" ref-type="bibr">56</xref>) and therapeutically relevant approaches to target pro-fibrotic macrophages have not been developed. In this study we found that specifically targeting overly stressed cardiomyocytes that express RAE-1 is highly effective in preventing development of cardiac fibrosis in hypertensive hearts. Treatment with the STING inhibitor H-151 not only greatly reduced fibrosis but also reduces cardiomyocyte loss due to apoptosis by preventing RAE-1 expression and targeted killing by CD8+ T cells; this greatly reduces TGF-&#x003b2;1 expression; therapeutically it should be possible to target RAE-1/NKG2D interactions. Increases in myocardial stiffness together with reductions in relaxation are major contributors to diastolic dysfunction in HFpEF and can be directly assessed by measuring cardiac pressures (<xref rid="B66" ref-type="bibr">66</xref>). Inhibiting STING as well as CD8+ T cell deletion significantly improved diastolic function in hypertensive hearts, independently of blood pressure and left ventricular hypertrophy. Previously STING deletion using siRNA was associated with a reduction in left ventricular hypertrophy (<xref rid="B67" ref-type="bibr">67</xref>), contrasting with our finding that following inhibition of STING palmitoylation with H-151 left ventricular hypertrophy is unaffected. Unfortunately, siRNA details were not provided. Chemical modification such a 2&#x0201d;-O-methyl modification of a single position in the siRNA guide strand is required to reduce most siRNA off-targeting silencing (<xref rid="B68" ref-type="bibr">68</xref>). STING inhibition using H-151 did not affect blood pressure, consistent with our finding of no effect on left ventricular hypertrophy. Together our findings indicate that STING signaling in overly stressed cardiomyocytes is critically important for development of hypertensive fibrosis. Whether STING inhibition is a suitable therapeutic strategy to prevent cardiac fibrosis remains to be determined, as inhibition can compromise immune responses to viral infections as well as cancer (<xref rid="B69" ref-type="bibr">69</xref>).</p><p>In summary, our data demonstrate that cytoplasmic DNA released in overly stressed cardiomyocytes in hypertensive hearts induces expression of the NKG2D ligand RAE-1 <italic>via</italic> the cGAS-STING pathway, which activates NKG2D+perforin+CD8+ T cells. These CD8+ T cells selectively target RAE-1 expressing cardiomyocytes inducing apoptosis. STING signaling in stressed cardiomyocytes also increases MCP-1 expression attracting macrophages and promoting phagocytosis which initiates TGF-&#x003b2;1 expression and development of interstitial cardiac fibrosis. Therapeutically, targeting RAE-1 to prevent RAE-1-NKG2D interactions may be a useful strategy to prevent interstitial fibrosis causing diastolic dysfunction in HFpEF.</p></sec><sec sec-type="data-availability" id="s5"><title>Data availability statement</title><p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></sec><sec sec-type="ethics-statement" id="s6"><title>Ethics statement</title><p>The animal study was reviewed and approved by Animal Ethics Committee at the Alfred Research Alliance, Melbourne, Australia.</p></sec><sec sec-type="author-contributions" id="s7"><title>Author contributions</title><p>TK, B-HT, KP and AB conceived and designed experiments. TK, PK, KB and AC performed experiments and analyzed data. TK drafted and TK, KB, B-HT, KP and AB wrote the manuscript. All authors contributed to the article and approved the submitted version.</p></sec><sec sec-type="funding-information" id="s8"><title>Funding</title><p>This work was supported by grants (APP1106151 to AB, B-HT, TK, APP1162251 to AB and B-HT) from the National Health and Medical Research Council of Australia.</p></sec><sec sec-type="COI-statement" id="s9"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="s10"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec></body><back><sec sec-type="supplementary-material" id="s11"><title>Supplementary material</title><p>The Supplementary Material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2022.1040233/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fimmu.2022.1040233/full#supplementary-material</ext-link>
</p><supplementary-material id="SF1" position="float" content-type="local-data"><label>Supplementary Figure&#x000a0;1</label><caption><p>CD8+ T cells promote cardiac fibrosis in mice with 2K1C-renal hypertension and with DOCA-salt hypertension. <bold>(A)</bold> Data showing depletion of CD8&#x003b1;&#x003b2;+ T cells in LV by anti-CD8&#x003b2; depleting antibodies compared with control mice with 2K1C-renal hypertension. <bold>(B)</bold> Systolic blood pressure (SBP) is unaffected by CD8&#x003b2; antibody treatment. <bold>(C)</bold> LV hypertrophy (LVS/BW) in 2K1C mice is unaffected by antibody treatment. <bold>(D)</bold> Photomicrographs showing the reduction in LV fibrosis in 2K1C mice associated with CD8&#x003b1;&#x003b2;+ T cell depletion. <bold>(E)</bold> CD8&#x003b1;&#x003b2;+ T cell depletion improves LV diastolic function in 2K1C-hypertensive mice. <bold>(F)</bold> CD8&#x003b1;&#x003b2;+ T cell depletion reduces cardiac cell TUNEL+ apoptotic cells. <bold>(G)</bold> CD8&#x003b2; antibody treatments reduces cardiac CD8+ T cells in mice with DOCA-salt hypertension compared to controls. <bold>(H)</bold> Systolic blood pressure and <bold>(I)</bold> LV hypertrophy are unaffected by CD8+ T cell depletion in mice with DOCA-salt hypertension. <bold>(J)</bold> Photomicrographs showing greatly reduced cardiac fibrosis in DOCA-salt hypertensive mice treated with anti-CD8&#x003b2; depleting antibodies. <bold>(K)</bold> LV diastolic function is improved following CD8+ T cell depletion in DOCA-salt hypertensive mice. <bold>(L)</bold> LV apoptotic cells are reduced following CD8+ T cell depletion in DOCA-salt mice. n=4-11/group. Results are means &#x000b1; SEM with small circles representing data from individual mice. scale bar represents 50&#x000b5;m. *P &#x0003c; 0.05 using two-tailed Student&#x02019;s t-test, comparing to either 2K1C+IgG or DOCA+IgG.</p></caption><media xlink:href="Image_1.tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SF2" position="float" content-type="local-data"><label>Supplementary Figure&#x000a0;2</label><caption><p>NK/NKT and TCR&#x003b3;&#x003b4; T cells express NKG2D receptors in TAC CD8T-NKG2D<sup>+/+</sup> mice. Mice were subjected to mixed chimeric approach (see text for detail) to generate mice with CD8+ T cell-specific NKG2D deficiency (CD8T-NKG2D<sup>-/-)</sup>. Representative photomicrographs demonstrating the expression of NKG2D in NK1.1+ and TCR&#x003b3;&#x003b4;+ cells accumulated in fibrotic areas of left ventricles in TAC CD8T-NKG2D<sup>-/-</sup> mice as well as TAC CD8T-NKG2D<sup>+/+</sup> control mice. scale bar represents 50&#x000b5;m.</p></caption><media xlink:href="Image_2.tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Fujiwara</surname><given-names>H</given-names></name><name><surname>Onodera</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>DJ</given-names></name><name><surname>Hamashima</surname><given-names>Y</given-names></name><name><surname>Kawai</surname><given-names>C</given-names></name></person-group>. <article-title>Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy</article-title>. <source>Br Heart J</source> (<year>1986</year>) <volume>55</volume>:<page-range>575&#x02013;81</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1136/hrt.55.6.575</pub-id>
</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Russo</surname><given-names>I</given-names></name><name><surname>Frangogiannis</surname><given-names>NG</given-names></name></person-group>. <article-title>Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities</article-title>. <source>J Mol Cell Cardiol</source> (<year>2016</year>) <volume>90</volume>:<fpage>84</fpage>&#x02013;<lpage>93</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.12.011</pub-id>
<pub-id pub-id-type="pmid">26705059</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Teo</surname><given-names>LY</given-names></name><name><surname>Chan</surname><given-names>LL</given-names></name><name><surname>Lam</surname><given-names>CS</given-names></name></person-group>. <article-title>Heart failure with preserved ejection fraction in hypertension</article-title>. <source>Curr Opin Cardiol</source> (<year>2016</year>) <volume>31</volume>:<page-range>410&#x02013;6</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1097/HCO.0000000000000292</pub-id>
</mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garg</surname><given-names>P</given-names></name><name><surname>Assadi</surname><given-names>H</given-names></name><name><surname>Jones</surname><given-names>R</given-names></name><name><surname>Chan</surname><given-names>WB</given-names></name><name><surname>Metherall</surname><given-names>P</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Left ventricular fibrosis and hypertrophy are associated with mortality in heart failure with preserved ejection fraction</article-title>. <source>Sci Rep</source> (<year>2021</year>) <volume>11</volume>:<fpage>617</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s41598-020-79729-6</pub-id>
<pub-id pub-id-type="pmid">33436786</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lam</surname><given-names>CSP</given-names></name><name><surname>Gamble</surname><given-names>GD</given-names></name><name><surname>Ling</surname><given-names>LH</given-names></name><name><surname>Sim</surname><given-names>D</given-names></name><name><surname>Leong</surname><given-names>KTG</given-names></name><name><surname>Yeo</surname><given-names>PSD</given-names></name><etal/></person-group>. <article-title>Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study</article-title>. <source>Eur Heart J</source> (<year>2018</year>) <volume>39</volume>:<page-range>1770&#x02013;80</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1093/eurheartj/ehy005</pub-id>
</mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sharma</surname><given-names>K</given-names></name><name><surname>Kass</surname><given-names>DA</given-names></name></person-group>. <article-title>Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies</article-title>. <source>Circ Res</source> (<year>2014</year>) <volume>115</volume>:<fpage>79</fpage>&#x02013;<lpage>96</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.302922</pub-id>
<pub-id pub-id-type="pmid">24951759</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cho</surname><given-names>JH</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Aynaszyan</surname><given-names>S</given-names></name><name><surname>Holm</surname><given-names>K</given-names></name><name><surname>Goldhaber</surname><given-names>JI</given-names></name><name><surname>Marban</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Ventricular arrhythmias underlie sudden death in rats with heart failure and preserved ejection fraction</article-title>. <source>Circ Arrhythm Electrophysiol</source> (<year>2018</year>) <volume>11</volume>:<elocation-id>e006452</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1161/CIRCEP.118.006452</pub-id>
<pub-id pub-id-type="pmid">30030266</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kuwahara</surname><given-names>F</given-names></name><name><surname>Kai</surname><given-names>H</given-names></name><name><surname>Tokuda</surname><given-names>K</given-names></name><name><surname>Kai</surname><given-names>M</given-names></name><name><surname>Takeshita</surname><given-names>A</given-names></name><name><surname>Egashira</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats</article-title>. <source>Circulation</source> (<year>2002</year>) <volume>106</volume>:<page-range>130&#x02013;5</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1161/01.cir.0000020689.12472.e0</pub-id>
</mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Midgley</surname><given-names>AC</given-names></name><name><surname>Rogers</surname><given-names>M</given-names></name><name><surname>Hallett</surname><given-names>MB</given-names></name><name><surname>Clayton</surname><given-names>A</given-names></name><name><surname>Bowen</surname><given-names>T</given-names></name><name><surname>Phillips</surname><given-names>AO</given-names></name><etal/></person-group>. <article-title>Transforming growth factor-beta1 (TGF-beta1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts</article-title>. <source>J Biol Chem</source> (<year>2013</year>) <volume>288</volume>:<page-range>14824&#x02013;38</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1074/jbc.M113.451336</pub-id>
</mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khalil</surname><given-names>H</given-names></name><name><surname>Kanisicak</surname><given-names>O</given-names></name><name><surname>Prasad</surname><given-names>V</given-names></name><name><surname>Correll</surname><given-names>RN</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Schips</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Fibroblast-specific TGF-beta-Smad2/3 signaling underlies cardiac fibrosis</article-title>. <source>J Clin Invest</source> (<year>2017</year>) <volume>127</volume>:<page-range>3770&#x02013;83</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1172/JCI94753</pub-id>
</mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Travis</surname><given-names>MA</given-names></name><name><surname>Sheppard</surname><given-names>D</given-names></name></person-group>. <article-title>TGF-beta activation and function in immunity</article-title>. <source>Annu Rev Immunol</source> (<year>2014</year>) <volume>32</volume>:<fpage>51</fpage>&#x02013;<lpage>82</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120257</pub-id>
<pub-id pub-id-type="pmid">24313777</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kanellakis</surname><given-names>P</given-names></name><name><surname>Ditiatkovski</surname><given-names>M</given-names></name><name><surname>Kostolias</surname><given-names>G</given-names></name><name><surname>Bobik</surname><given-names>A</given-names></name></person-group>. <article-title>A pro-fibrotic role for interleukin-4 in cardiac pressure overload</article-title>. <source>Cardiovasc Res</source> (<year>2012</year>) <volume>95</volume>:<fpage>77</fpage>&#x02013;<lpage>85</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1093/cvr/cvs142</pub-id>
<pub-id pub-id-type="pmid">22492684</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hulsmans</surname><given-names>M</given-names></name><name><surname>Sager</surname><given-names>HB</given-names></name><name><surname>Roh</surname><given-names>JD</given-names></name><name><surname>Valero-Munoz</surname><given-names>M</given-names></name><name><surname>Houstis</surname><given-names>NE</given-names></name><name><surname>Iwamoto</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Cardiac macrophages promote diastolic dysfunction</article-title>. <source>J Exp Med</source> (<year>2018</year>) <volume>215</volume>:<page-range>423&#x02013;40</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1084/jem.20171274</pub-id>
</mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kanellakis</surname><given-names>P</given-names></name><name><surname>Dinh</surname><given-names>TN</given-names></name><name><surname>Agrotis</surname><given-names>A</given-names></name><name><surname>Bobik</surname><given-names>A</given-names></name></person-group>. <article-title>CD4(+)CD25(+)Foxp3(+) regulatory T cells suppress cardiac fibrosis in the hypertensive heart</article-title>. <source>J Hypertens</source> (<year>2011</year>) <volume>29</volume>:<page-range>1820&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1097/HJH.0b013e328349c62d</pub-id>
</mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nevers</surname><given-names>T</given-names></name><name><surname>Salvador</surname><given-names>AM</given-names></name><name><surname>Velazquez</surname><given-names>F</given-names></name><name><surname>Ngwenyama</surname><given-names>N</given-names></name><name><surname>Carrillo-Salinas</surname><given-names>FJ</given-names></name><name><surname>Aronovitz</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure</article-title>. <source>J Exp Med</source> (<year>2017</year>) <volume>214</volume>:<page-range>3311&#x02013;29</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1084/jem.20161791</pub-id>
</mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Laroumanie</surname><given-names>F</given-names></name><name><surname>Douin-Echinard</surname><given-names>V</given-names></name><name><surname>Pozzo</surname><given-names>J</given-names></name><name><surname>Lairez</surname><given-names>O</given-names></name><name><surname>Tortosa</surname><given-names>F</given-names></name><name><surname>Vinel</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>CD4+ T cells promote the transition from hypertrophy to heart failure during chronic pressure overload</article-title>. <source>Circulation</source> (<year>2014</year>) <volume>129</volume>:<page-range>2111&#x02013;24</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.007101</pub-id>
</mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ma</surname><given-names>F</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Qi</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>The requirement of CD8+ T cells to initiate and augment acute cardiac inflammatory response to high blood pressure</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>:<page-range>3365&#x02013;73</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.4049/jimmunol.1301522</pub-id>
</mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Groschel</surname><given-names>C</given-names></name><name><surname>Sasse</surname><given-names>A</given-names></name><name><surname>Monecke</surname><given-names>S</given-names></name><name><surname>Rohrborn</surname><given-names>C</given-names></name><name><surname>Elsner</surname><given-names>L</given-names></name><name><surname>Didie</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>CD8(+)-T cells with specificity for a model antigen in cardiomyocytes can become activated after transverse aortic constriction but do not accelerate progression to heart failure</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>2665</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.02665</pub-id>
<pub-id pub-id-type="pmid">30498501</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wheeler</surname><given-names>CJ</given-names></name><name><surname>von Hoegen</surname><given-names>P</given-names></name><name><surname>Parnes</surname><given-names>JR</given-names></name></person-group>. <article-title>An immunological role for the CD8 beta-chain</article-title>. <source>Nature</source> (<year>1992</year>) <volume>357</volume>:<page-range>247&#x02013;9</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/357247a0</pub-id>
</mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chu</surname><given-names>T</given-names></name><name><surname>Tyznik</surname><given-names>AJ</given-names></name><name><surname>Roepke</surname><given-names>S</given-names></name><name><surname>Berkley</surname><given-names>AM</given-names></name><name><surname>Woodward-Davis</surname><given-names>A</given-names></name><name><surname>Pattacini</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner</article-title>. <source>Cell Rep</source> (<year>2013</year>) <volume>3</volume>:<page-range>701&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.celrep.2013.02.020</pub-id>
</mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xiong</surname><given-names>W</given-names></name><name><surname>Frasch</surname><given-names>SC</given-names></name><name><surname>Thomas</surname><given-names>SM</given-names></name><name><surname>Bratton</surname><given-names>DL</given-names></name><name><surname>Henson</surname><given-names>PM</given-names></name></person-group>. <article-title>Induction of TGF-beta1 synthesis by macrophages in response to apoptotic cells requires activation of the scavenger receptor CD36</article-title>. <source>PloS One</source> (<year>2013</year>) <volume>8</volume>:<elocation-id>e72772</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1371/journal.pone.0072772</pub-id>
<pub-id pub-id-type="pmid">23936544</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Obberghen-Schilling</surname><given-names>E</given-names></name><name><surname>Roche</surname><given-names>NS</given-names></name><name><surname>Flanders</surname><given-names>KC</given-names></name><name><surname>Sporn</surname><given-names>MB</given-names></name><name><surname>Roberts</surname><given-names>AB</given-names></name></person-group>. <article-title>Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells</article-title>. <source>J Biol Chem</source> (<year>1988</year>) <volume>263</volume>:<page-range>7741&#x02013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0021-9258(18)68561-8</pub-id>
</mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Agrotis</surname><given-names>A</given-names></name><name><surname>Saltis</surname><given-names>J</given-names></name><name><surname>Bobik</surname><given-names>A</given-names></name></person-group>. <article-title>Transforming growth factor-beta 1 gene activation and growth of smooth muscle from hypertensive rats</article-title>. <source>Hypertension</source> (<year>1994</year>) <volume>23</volume>:<page-range>593&#x02013;9</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1161/01.hyp.23.5.593</pub-id>
</mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tay</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>YH</given-names></name><name><surname>Kanellakis</surname><given-names>P</given-names></name><name><surname>Kallies</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Cao</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Follicular b cells promote atherosclerosis <italic>via</italic> T cell-mediated differentiation into plasma cells and secreting pathogenic immunoglobulin G</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2018</year>) <volume>38</volume>:<page-range>e71&#x02013;84</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1161/ATVBAHA.117.310678</pub-id>
</mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wiesel</surname><given-names>P</given-names></name><name><surname>Mazzolai</surname><given-names>L</given-names></name><name><surname>Nussberger</surname><given-names>J</given-names></name><name><surname>Pedrazzini</surname><given-names>T</given-names></name></person-group>. <article-title>Two-kidney, one clip and one-kidney, one clip hypertension in mice</article-title>. <source>Hypertension</source> (<year>1997</year>) <volume>29</volume>:<page-range>1025&#x02013;30</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1161/01.hyp.29.4.1025</pub-id>
</mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ortiz</surname><given-names>PA</given-names></name><name><surname>Garvin</surname><given-names>JL</given-names></name></person-group>. <article-title>Intrarenal transport and vasoactive substances in hypertension</article-title>. <source>Hypertension</source> (<year>2001</year>) <volume>38</volume>:<page-range>621&#x02013;4</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1161/hy09t1.093361</pub-id>
</mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kanellakis</surname><given-names>P</given-names></name><name><surname>Pomilio</surname><given-names>G</given-names></name><name><surname>Agrotis</surname><given-names>A</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Du</surname><given-names>XJ</given-names></name><name><surname>Curtis</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Darbepoetin-mediated cardioprotection after myocardial infarction involves multiple mechanisms independent of erythropoietin receptor-common beta-chain heteroreceptor</article-title>. <source>Br J Pharmacol</source> (<year>2010</year>) <volume>160</volume>:<page-range>2085&#x02013;96</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/j.1476-5381.2010.00876.x</pub-id>
</mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haag</surname><given-names>SM</given-names></name><name><surname>Gulen</surname><given-names>MF</given-names></name><name><surname>Reymond</surname><given-names>L</given-names></name><name><surname>Gibelin</surname><given-names>A</given-names></name><name><surname>Abrami</surname><given-names>L</given-names></name><name><surname>Decout</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Targeting STING with covalent small-molecule inhibitors</article-title>. <source>Nature</source> (<year>2018</year>) <volume>559</volume>:<page-range>269&#x02013;73</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s41586-018-0287-8</pub-id>
</mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Shang</surname><given-names>G</given-names></name><name><surname>Gui</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>XC</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group>. <article-title>Structural basis of STING binding with and phosphorylation by TBK1</article-title>. <source>Nature</source> (<year>2019</year>) <volume>567</volume>:<page-range>394&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s41586-019-1000-2</pub-id>
</mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gasser</surname><given-names>R</given-names></name><name><surname>Cloutier</surname><given-names>M</given-names></name><name><surname>Prevost</surname><given-names>J</given-names></name><name><surname>Fink</surname><given-names>C</given-names></name><name><surname>Ducas</surname><given-names>E</given-names></name><name><surname>Ding</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2</article-title>. <source>Cell Rep</source> (<year>2021</year>) <volume>34</volume>:<elocation-id>108790</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.celrep.2021.108790</pub-id>
<pub-id pub-id-type="pmid">33596407</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baba</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Tanabe</surname><given-names>Y</given-names></name><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Morishita</surname><given-names>S</given-names></name><name><surname>Gotoh</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Cytoplasmic DNA accumulation preferentially triggers cell death of myeloid leukemia cells by interacting with intracellular DNA sensing pathway</article-title>. <source>Cell Death Dis</source> (<year>2021</year>) <volume>12</volume>:<fpage>322</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s41419-021-03587-x</pub-id>
<pub-id pub-id-type="pmid">33771977</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kyaw</surname><given-names>T</given-names></name><name><surname>Winship</surname><given-names>A</given-names></name><name><surname>Tay</surname><given-names>C</given-names></name><name><surname>Kanellakis</surname><given-names>P</given-names></name><name><surname>Hosseini</surname><given-names>H</given-names></name><name><surname>Cao</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice</article-title>. <source>Circulation</source> (<year>2013</year>) <volume>127</volume>:<page-range>1028&#x02013;39</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.001347</pub-id>
</mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kiriazis</surname><given-names>H</given-names></name><name><surname>Tugiono</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Gao</surname><given-names>XM</given-names></name><name><surname>Jennings</surname><given-names>NL</given-names></name><name><surname>Ming</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Chronic activation of the low affinity site of beta1-adrenoceptors stimulates haemodynamics but exacerbates pressure-overload cardiac remodelling</article-title>. <source>Br J Pharmacol</source> (<year>2013</year>) <volume>170</volume>:<page-range>352&#x02013;65</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/bph.12272</pub-id>
</mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kuwahara</surname><given-names>F</given-names></name><name><surname>Kai</surname><given-names>H</given-names></name><name><surname>Tokuda</surname><given-names>K</given-names></name><name><surname>Takeya</surname><given-names>M</given-names></name><name><surname>Takeshita</surname><given-names>A</given-names></name><name><surname>Egashira</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation</article-title>? <source>Hypertension</source> (<year>2004</year>) <volume>43</volume>:<page-range>739&#x02013;45</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1161/01.HYP.0000118584.33350.7d</pub-id>
</mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elliott</surname><given-names>MR</given-names></name><name><surname>Chekeni</surname><given-names>FB</given-names></name><name><surname>Trampont</surname><given-names>PC</given-names></name><name><surname>Lazarowski</surname><given-names>ER</given-names></name><name><surname>Kadl</surname><given-names>A</given-names></name><name><surname>Walk</surname><given-names>SF</given-names></name><etal/></person-group>. <article-title>Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance</article-title>. <source>Nature</source> (<year>2009</year>) <volume>461</volume>:<page-range>282&#x02013;6</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/nature08296</pub-id>
</mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bottcher</surname><given-names>JP</given-names></name><name><surname>Beyer</surname><given-names>M</given-names></name><name><surname>Meissner</surname><given-names>F</given-names></name><name><surname>Abdullah</surname><given-names>Z</given-names></name><name><surname>Sander</surname><given-names>J</given-names></name><name><surname>Hochst</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Functional classification of memory CD8(+) T cells by CX3CR1 expression</article-title>. <source>Nat Commun</source> (<year>2015</year>) <volume>6</volume>:<fpage>8306</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/ncomms9306</pub-id>
<pub-id pub-id-type="pmid">26404698</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cullen</surname><given-names>JG</given-names></name><name><surname>McQuilten</surname><given-names>HA</given-names></name><name><surname>Quinn</surname><given-names>KM</given-names></name><name><surname>Olshansky</surname><given-names>M</given-names></name><name><surname>Russ</surname><given-names>BE</given-names></name><name><surname>Morey</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>CD4(+) T help promotes influenza virus-specific CD8(+) T cell memory by limiting metabolic dysfunction</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2019</year>) <volume>116</volume>:<page-range>4481&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1073/pnas.1808849116</pub-id>
</mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Novy</surname><given-names>P</given-names></name><name><surname>Quigley</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name></person-group>. <article-title>CD4 T cells are required for CD8 T cell survival during both primary and memory recall responses</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>179</volume>:<page-range>8243&#x02013;51</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.4049/jimmunol.179.12.8243</pub-id>
</mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Booty</surname><given-names>MG</given-names></name><name><surname>Nunes-Alves</surname><given-names>C</given-names></name><name><surname>Carpenter</surname><given-names>SM</given-names></name><name><surname>Jayaraman</surname><given-names>P</given-names></name><name><surname>Behar</surname><given-names>SM</given-names></name></person-group>. <article-title>Multiple inflammatory cytokines converge to regulate CD8+ T cell expansion and function during tuberculosis</article-title>. <source>J Immunol</source> (<year>2016</year>) <volume>196</volume>:<page-range>1822&#x02013;31</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.4049/jimmunol.1502206</pub-id>
</mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kourtzelis</surname><given-names>I</given-names></name><name><surname>Hajishengallis</surname><given-names>G</given-names></name><name><surname>Chavakis</surname><given-names>T</given-names></name></person-group>. <article-title>Phagocytosis of apoptotic cells in resolution of inflammation</article-title>. <source>Front Immunol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>553</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.00553</pub-id>
<pub-id pub-id-type="pmid">32296442</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maderna</surname><given-names>P</given-names></name><name><surname>Godson</surname><given-names>C</given-names></name></person-group>. <article-title>Phagocytosis of apoptotic cells and the resolution of inflammation</article-title>. <source>Biochim Biophys Acta</source> (<year>2003</year>) <volume>1639</volume>:<page-range>141&#x02013;51</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.bbadis.2003.09.004</pub-id>
</mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nacu</surname><given-names>N</given-names></name><name><surname>Luzina</surname><given-names>IG</given-names></name><name><surname>Highsmith</surname><given-names>K</given-names></name><name><surname>Lockatell</surname><given-names>V</given-names></name><name><surname>Pochetuhen</surname><given-names>K</given-names></name><name><surname>Cooper</surname><given-names>ZA</given-names></name><etal/></person-group>. <article-title>Macrophages produce TGF-beta-induced (beta-ig-h3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>180</volume>:<page-range>5036&#x02013;44</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.4049/jimmunol.180.7.5036</pub-id>
</mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Dou</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Mitochondrial DNA leakage caused by streptococcus pneumoniae hydrogen peroxide promotes type I IFN expression in lung cells</article-title>. <source>Front Microbiol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>630</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3389/fmicb.2019.00630</pub-id>
<pub-id pub-id-type="pmid">30984149</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fang</surname><given-names>C</given-names></name><name><surname>Mo</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>Men</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Oxidized mitochondrial DNA sensing by STING signaling promotes the antitumor effect of an irradiated immunogenic cancer cell vaccine</article-title>. <source>Cell Mol Immunol</source> (<year>2020</year>) <volume>18</volume>:<page-range>2211&#x02013;23</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s41423-020-0456-1</pub-id>
</mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lam</surname><given-names>AR</given-names></name><name><surname>Bert</surname><given-names>NL</given-names></name><name><surname>Ho</surname><given-names>SS</given-names></name><name><surname>Shen</surname><given-names>YJ</given-names></name><name><surname>Tang</surname><given-names>LF</given-names></name><name><surname>Xiong</surname><given-names>GM</given-names></name><etal/></person-group>. <article-title>RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma</article-title>. <source>Cancer Res</source> (<year>2014</year>) <volume>74</volume>:<page-range>2193&#x02013;203</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-1703</pub-id>
</mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shen</surname><given-names>YJ</given-names></name><name><surname>Le Bert</surname><given-names>N</given-names></name><name><surname>Chitre</surname><given-names>AA</given-names></name><name><surname>Koo</surname><given-names>CX</given-names></name><name><surname>Nga</surname><given-names>XH</given-names></name><name><surname>Ho</surname><given-names>SS</given-names></name><etal/></person-group>. <article-title>Genome-derived cytosolic DNA mediates type I interferon-dependent rejection of b cell lymphoma cells</article-title>. <source>Cell Rep</source> (<year>2015</year>) <volume>11</volume>:<page-range>460&#x02013;73</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.celrep.2015.03.041</pub-id>
</mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hansen</surname><given-names>AL</given-names></name><name><surname>Mukai</surname><given-names>K</given-names></name><name><surname>Schopfer</surname><given-names>FJ</given-names></name><name><surname>Taguchi</surname><given-names>T</given-names></name><name><surname>Holm</surname><given-names>CK</given-names></name></person-group>. <article-title>STING palmitoylation as a therapeutic target</article-title>. <source>Cell Mol Immunol</source> (<year>2019</year>) <volume>16</volume>:<page-range>236&#x02013;41</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s41423-019-0205-5</pub-id>
</mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rovin</surname><given-names>BH</given-names></name><name><surname>Dickerson</surname><given-names>JA</given-names></name><name><surname>Tan</surname><given-names>LC</given-names></name><name><surname>Hebert</surname><given-names>CA</given-names></name></person-group>. <article-title>Activation of nuclear factor-kappa b correlates with MCP-1 expression by human mesangial cells</article-title>. <source>Kidney Int</source> (<year>1995</year>) <volume>48</volume>:<page-range>1263&#x02013;71</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/ki.1995.410</pub-id>
</mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Takaishi</surname><given-names>H</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Ishikawa</surname><given-names>Y</given-names></name><name><surname>Yokoyama</surname><given-names>M</given-names></name></person-group>. <article-title>High glucose accelerates MCP-1 production <italic>via</italic> p38 MAPK in vascular endothelial cells</article-title>. <source>Biochem Biophys Res Commun</source> (<year>2003</year>) <volume>305</volume>:<page-range>122&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/s0006-291x(03)00712-5</pub-id>
</mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Terada</surname><given-names>M</given-names></name><name><surname>Ariyoshi</surname><given-names>K</given-names></name><name><surname>Morimoto</surname><given-names>K</given-names></name></person-group>. <article-title>Monocyte chemoattractant protein-1/CC chemokine ligand 2 enhances apoptotic cell removal by macrophages through Rac1 activation</article-title>. <source>Biochem Biophys Res Commun</source> (<year>2010</year>) <volume>399</volume>:<page-range>677&#x02013;82</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.bbrc.2010.07.141</pub-id>
</mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>TS</given-names></name><name><surname>Shin</surname><given-names>EC</given-names></name></person-group>. <article-title>The activation of bystander CD8(+) T cells and their roles in viral infection</article-title>. <source>Exp Mol Med</source> (<year>2019</year>) <volume>51</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s12276-019-0316-1</pub-id>
</mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>A</given-names></name><name><surname>Lopez</surname><given-names>B</given-names></name><name><surname>Ravassa</surname><given-names>S</given-names></name><name><surname>Querejeta</surname><given-names>R</given-names></name><name><surname>Larman</surname><given-names>M</given-names></name><name><surname>Diez</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II</article-title>. <source>Hypertension</source> (<year>2002</year>) <volume>39</volume>:<fpage>75</fpage>&#x02013;<lpage>80</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1161/hy0102.100788</pub-id>
<pub-id pub-id-type="pmid">11799082</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Okada</surname><given-names>K</given-names></name><name><surname>Minamino</surname><given-names>T</given-names></name><name><surname>Tsukamoto</surname><given-names>Y</given-names></name><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Tsukamoto</surname><given-names>O</given-names></name><name><surname>Takashima</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis</article-title>. <source>Circulation</source> (<year>2004</year>) <volume>110</volume>:<page-range>705&#x02013;12</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1161/01.CIR.0000137836.95625.D4</pub-id>
</mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Carretero</surname><given-names>OA</given-names></name><name><surname>Liao</surname><given-names>TD</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Shesely</surname><given-names>EG</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Local angiotensin II aggravates cardiac remodeling in hypertension</article-title>. <source>Am J Physiol Heart Circ Physiol</source> (<year>2010</year>) <volume>299</volume>:<page-range>H1328&#x02013;1338</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1152/ajpheart.00538.2010</pub-id>
</mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Komai</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Nomura</surname><given-names>S</given-names></name><name><surname>Shichino</surname><given-names>S</given-names></name><name><surname>Katoh</surname><given-names>M</given-names></name><name><surname>Yamada</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Single-cell analysis revealed the role of CD8(+) effector T cells in preventing cardioprotective macrophage differentiation in the early phase of heart failure</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>763647</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.763647</pub-id>
<pub-id pub-id-type="pmid">34745139</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aghajanian</surname><given-names>H</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Rurik</surname><given-names>JG</given-names></name><name><surname>Hancock</surname><given-names>AS</given-names></name><name><surname>Leibowitz</surname><given-names>MS</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Targeting cardiac fibrosis with engineered T cells</article-title>. <source>Nature</source> (<year>2019</year>) <volume>573</volume>:<page-range>430&#x02013;3</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s41586-019-1546-z</pub-id>
</mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turner</surname><given-names>NA</given-names></name></person-group>. <article-title>Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs)</article-title>. <source>J Mol Cell Cardiol</source> (<year>2016</year>) <volume>94</volume>:<fpage>189</fpage>&#x02013;<lpage>200</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.11.002</pub-id>
<pub-id pub-id-type="pmid">26542796</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Xue</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name></person-group>. <article-title>Exosomes derived from cardiomyocytes promote cardiac fibrosis <italic>via</italic> myocyte-fibroblast cross-talk</article-title>. <source>Am J Transl Res</source> (<year>2018</year>) <volume>10</volume>:<page-range>4350&#x02013;66</page-range>.</mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tokuyama</surname><given-names>M</given-names></name><name><surname>Lorin</surname><given-names>C</given-names></name><name><surname>Delebecque</surname><given-names>F</given-names></name><name><surname>Jung</surname><given-names>H</given-names></name><name><surname>Raulet</surname><given-names>DH</given-names></name><name><surname>Coscoy</surname><given-names>L</given-names></name></person-group>. <article-title>Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation</article-title>. <source>PloS Pathog</source> (<year>2011</year>) <volume>7</volume>:<elocation-id>e1002265</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1002265</pub-id>
<pub-id pub-id-type="pmid">21966273</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bi</surname><given-names>X</given-names></name><name><surname>Du</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>XY</given-names></name><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Mitochondrial damage-induced innate immune activation in vascular smooth muscle cells promotes chronic kidney disease-associated plaque vulnerability</article-title>. <source>Adv Sci (Weinh)</source> (<year>2021</year>) <volume>8</volume>:<elocation-id>2002738</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/advs.202002738</pub-id>
<pub-id pub-id-type="pmid">33717842</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Combates</surname><given-names>NJ</given-names></name><name><surname>Degiannis</surname><given-names>D</given-names></name><name><surname>Raskova</surname><given-names>J</given-names></name><name><surname>Raska</surname><given-names>K</given-names><suffix>Jr</suffix></name></person-group>. <article-title>Direct inhibition of human CD8+ lymphocyte activation by cyclosporine a and rapamune-sirolimus</article-title>. <source>Clin Immunol Immunopathol</source> (<year>1995</year>) <volume>77</volume>:<page-range>221&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1006/clin.1995.1147</pub-id>
</mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Cui</surname><given-names>YX</given-names></name><name><surname>Wu</surname><given-names>MY</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Su</surname><given-names>LN</given-names></name><name><surname>Lian</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Cytosolic DNA sensor cGAS plays an essential pathogenetic role in pressure overload-induced heart failure</article-title>. <source>Am J Physiol Heart Circ Physiol</source> (<year>2020</year>) <volume>318</volume>:<page-range>H1525&#x02013;37</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1152/ajpheart.00097.2020</pub-id>
</mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group>. <article-title>cGAS is essential for cellular senescence</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2017</year>) <volume>114</volume>:<page-range>E4612&#x02013;20</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1073/pnas.1705499114</pub-id>
</mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zander</surname><given-names>R</given-names></name><name><surname>Schauder</surname><given-names>D</given-names></name><name><surname>Xin</surname><given-names>G</given-names></name><name><surname>Nguyen</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Zajac</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>CD4(+) T cell help is required for the formation of a cytolytic CD8(+) T cell subset that protects against chronic infection and cancer</article-title>. <source>Immunity</source> (<year>2019</year>) <volume>51</volume>:<fpage>1028</fpage>&#x02013;<lpage>1042 e1024</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.immuni.2019.10.009</pub-id>
<pub-id pub-id-type="pmid">31810883</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sweeney</surname><given-names>M</given-names></name><name><surname>Corden</surname><given-names>B</given-names></name><name><surname>Cook</surname><given-names>SA</given-names></name></person-group>. <article-title>Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle</article-title>? <source>EMBO Mol Med</source> (<year>2020</year>) <volume>12</volume>:<fpage>e10865</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.15252/emmm.201910865</pub-id>
<pub-id pub-id-type="pmid">32955172</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ogilvie</surname><given-names>LM</given-names></name><name><surname>Edgett</surname><given-names>BA</given-names></name><name><surname>Huber</surname><given-names>JS</given-names></name><name><surname>Platt</surname><given-names>MJ</given-names></name><name><surname>Eberl</surname><given-names>HJ</given-names></name><name><surname>Lutchmedial</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Hemodynamic assessment of diastolic function for experimental models</article-title>. <source>Am J Physiol Heart Circ Physiol</source> (<year>2020</year>) <volume>318</volume>:<page-range>H1139&#x02013;58</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1152/ajpheart.00705.2019</pub-id>
</mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>. <article-title>STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy <italic>via</italic> endoplasmic reticulum (ER) stress</article-title>. <source>BioMed Pharmacother</source> (<year>2020</year>) <volume>125</volume>:<elocation-id>110022</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.biopha.2020.110022</pub-id>
<pub-id pub-id-type="pmid">32106379</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jackson</surname><given-names>AL</given-names></name><name><surname>Linsley</surname><given-names>PS</given-names></name></person-group>. <article-title>Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application</article-title>. <source>Nat Rev Drug Discovery</source> (<year>2010</year>) <volume>9</volume>:<fpage>57</fpage>&#x02013;<lpage>67</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/nrd3010</pub-id>
<pub-id pub-id-type="pmid">20043028</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barber</surname><given-names>GN</given-names></name></person-group>. <article-title>STING: infection, inflammation and cancer</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>:<page-range>760&#x02013;70</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/nri3921</pub-id>
</mixed-citation></ref></ref-list></back></article>